Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Say Bee Poh"'
Autor:
Yan Xiong, Hua Guo, Wen Chien Huang, Zhaoxi Ding, Shau Hsuan Li, Siyuan Zhang, Ping Li, Say Bee Poh, Samuel W. Brady, Gabriel N. Hortobagyi, Francisco J. Esteva, Dihua Yu, Ling Ming Tseng, Aysegul A. Sahin
Publikováno v:
Nature Medicine. 17:461-469
Trastuzumab is a successful rationally designed ERBB2-targeted therapy. However, about half of individuals with ERBB2-overexpressing breast cancer do not respond to trastuzumab-based therapies, owing to various resistance mechanisms. Clinically appli
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::247c2b53a4a6d2c0eb80107f71ea853b
https://doi.org/10.1038/nm.2309
https://doi.org/10.1038/nm.2309
Autor:
Pang Chan Lin, Jin Hwang Liu, Wei Shu Wang, Ming Yang Lee, Po Min Chen, Muh Hwa Yang, Liang Tsai Hsiao, Chueh Chuan Yen, Say Bee Poh, Hao Wei Teng, Ta Chung Chao, Tzeon Jye Chiou
Publikováno v:
Annals of Hematology. 87:285-289
The use of monoclonal antibody, rituximab, had been reported to be associated with some severe viral infections. The inference of rituximab therapy and post-transplant cytomegalovirus (CMV) infectious complications in non-Hodgkin's lymphoma (NHL) pat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::460f56ba0db6c538eaf1af9a30a6366d
https://doi.org/10.1007/s00277-007-0397-0
https://doi.org/10.1007/s00277-007-0397-0
Autor:
Po Min Chen, Jin Hwang Liu, Say Bee Poh, Wei Shu Wang, Peng Chan Lin, Liang Tsai Hsiao, Chueh Chuan Yen, Ta Chung Chao, Tzeon Jye Chiou
Publikováno v:
Annals of Hematology. 86:95-100
Although adding rituximab to standard cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) chemotherapy is an efficacious and well-tolerated regimen in elderly patients with diffuse large B cell lymphoma (DLBCL), it may increase suscepti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cb445f5cbf2709fac5a1e34df8d56d32
https://doi.org/10.1007/s00277-006-0191-4
https://doi.org/10.1007/s00277-006-0191-4
Publikováno v:
American Journal of Clinical Oncology. 28:540-546
Objectives: Effective chemotherapy with the least toxicity is important for patients with inoperable or advanced hepatocellular carcinoma. Single use of pegylated liposomal doxorubicin has been reported to be safe and effective with varying treatment
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a23351d7d731adedcc93f2ecf2ad96cd
https://doi.org/10.1097/01.coc.0000177911.36579.3d
https://doi.org/10.1097/01.coc.0000177911.36579.3d
Publikováno v:
International Journal of Hematology. 81:349-351
Hepatitis B virus (HBV) reactivation can give rise to acute hepatitis and even fatal fulminant hepatitis in patients receiving immunosuppressive or cytostatic treatment. Recently, the prophylactic use of lamivudine for HBV reactivation in HBV surface
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0130c0b7dfb9ade4a1d7fe5b9fb91b63
https://doi.org/10.1532/ijh97.a10411
https://doi.org/10.1532/ijh97.a10411
Publikováno v:
Biology of Blood and Marrow Transplantation. 11(9):732-733
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::36ce987597ee5a371e57d485d400ea47
Autor:
Hua Guo, Yan Xiong, Say-Bee Poh, Zhaoxi Ding, Wen-Chien Huang, Samuel W. Brady, Gabriel N. Hortobagyi, Shau-Hsuan Li, Francisco J. Esteva, Siyuan Zhang, Dihua Yu, Ping Li, Aysegul Sahin, Ling-Ming Tseng
Publikováno v:
Cancer Research. 71:LB-379
Objective of the study: Trastuzumab is a highly successful example of rationally designed ERBB2-targeted therapy. However, about half of patients with ERBB2-overexpressing breast cancer do not respond to trastuzumab-based therapies due to various res
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::364e4a680a3e2819c0de62dfe5f9f2fd
https://doi.org/10.1158/1538-7445.am2011-lb-379
https://doi.org/10.1158/1538-7445.am2011-lb-379
Publikováno v:
European Journal of Haematology. 75:359-359
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b645e35512377db7ebe9d8309457c801
https://doi.org/10.1111/j.1600-0609.2005.00520.x
https://doi.org/10.1111/j.1600-0609.2005.00520.x
Autor:
Siyuan Zhang, Wen-Chien Huang, Ping Li, Hua Guo, Say-Bee Poh, Brady, Samuel W., Yan Xiong, Ling-Ming Tseng, Shau-Hsuan Li, Zhaoxi Ding, Sahin, Aysegul A., Esteva, Francisco J., Hortobagyi, Gabriel N., Dihua Yu
Publikováno v:
Nature Medicine; Apr2011, Vol. 17 Issue 4, p461-469, 9p, 1 Black and White Photograph, 5 Graphs
Publikováno v:
European Journal of Haematology. Oct2005, Vol. 75 Issue 4, p359-359. 1p.